Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06596616

Gadopiclenol vs Gadoxetate MRI for Liver Lesions

Sponsor: Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

The overall purpose of this study is to establish noninferiority of gadopiclenol MRI compared to gadoxetate MRI in terms of image quality and lesion detection/conspicuity in patients undergoing clinically indicated liver MRI in a prospective study. The research will be utilizing MRI; with enrollment goal of 75 subjects over the course of two years.

Official title: MR Image Quality and Liver Lesion Detection With Gadopiclenol: Comparison With Gadoxetate Disodium

Key Details

Gender

All

Age Range

18 Years - 89 Years

Study Type

OBSERVATIONAL

Enrollment

75

Start Date

2024-07-01

Completion Date

2026-03-27

Last Updated

2025-07-29

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Radiology

Radiology - MRI Scans

OTHER

Gadopiclenol

Gadopiclenol is a new macrocyclic gadolinium-based contrast agent (GBCA)

Locations (1)

BMEII

New York, New York, United States